Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    3 days ago
    Change Detected
    Summary
    An NIH banner announces a terminology change from “Artificial Intelligence” to “Super Intelligence” during a website transition.
    Difference
    0.3%
    Check dated 2026-10-26T16:42:57.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-19T21:51:17.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.0%
    Check dated 2026-10-13T04:21:17.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The revision label changes from v3.6.6 to v3.7.0, indicating a software version update. This does not modify the study data, navigation, or visible content on the page.
    Difference
    0.0%
    Check dated 2026-09-21T22:48:29.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The history now shows a new revision v3.6.6 replacing v3.6.5, signaling a published update to the page's version.
    Difference
    0.0%
    Check dated 2026-08-31T17:28:32.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    A new version (65) was added to the study history on 2026-08-19/20, updating the Study Status and Contacts/Locations sections; the version dated 2026-05-28 was removed from the history.
    Difference
    0.2%
    Check dated 2026-08-24T17:22:21.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.